BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Health2Sync Secures Over $20M in Series C Funding to Drive Global Expansion and AI-Driven Chronic Disease Management

Health2Sync (H2), a leading digital health company specializing in chronic disease management, today announced it has raised over US$20 million in a Series...

March 05, 2025 | News

MojiaBio and A*STAR Partner to Develop SGD 44.8 Million Sustainable Biomanufacturing Technology Platform in Singapore

MojiaBio, a global leader in green chemistry and sustainable biomanufacturing, has announced a strategic partnership with the Agency for Science, Technolog...

March 03, 2025 | News

Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical...

February 27, 2025 | News

CARsgen Therapeutics and Zhuhai SB Xinchuang Partner to Advance Allogeneic CAR-T Therapies in China

CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...

February 26, 2025 | News

Duke and Duke-NUS Award Over S$1 Million for Climate and Health Research in Landmark Collaboration

The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration Dedicated Research Collaborati...

February 17, 2025 | News

Bambusa Therapeutics Closes $90 Million Series A to Advance Bispecific Antibody Pipeline for Immunological and Inflammatory Disorders

Bambusa Therapeutics, Inc. (Bambusa), a biotechnology company developing bispecific antibodies for immunological and inflammatory (I&I) disorders, anno...

February 17, 2025 | News

GE HealthCare Invests $138M to Expand Ireland Facility, Boosting Global Contrast Media Supply

New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the en...

February 03, 2025 | News

GHIT Fund Invests JPY 2 Billion (USD 12.7M) in Diagnostics and Drug Development for NTDs and Malaria

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million) in eight projects ...

January 30, 2025 | News

AB2 Bio and Nippon Shinyaku Forge U.S.-Japan Licensing Deal to Launch Tadekinig Alfa for Rare Hyperinflammatory Syndrome

Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic IL...

January 28, 2025 | News

Beckman Coulter and Indiana University School of Medicine Secure $2.5M Grant to Enhance Leukemia and Lymphoma Testing in Western Kenya

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been awa...

January 22, 2025 | News

GordonMD and South Korea’s Partners Investment Join Forces to Drive Biopharma Innovation

GordonMD Global Investments® LP (“GordonMD”), a US-based investment manager focused exclusively on global public and private biopharma...

January 22, 2025 | News

R-Bridge Healthcare Fund Provides $40M Financing to Mirxes to Accelerate Global Expansion of Cancer Early Detection Solutions

R-Bridge will provide bespoke financing of US$40 million with a synthetic royalty structure and f...

January 14, 2025 | News

Aragen Secures $100 Mn Investment from Quadria Capital, Valued at $1.4 Bn

Aragen, a globally renowned Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has secured a $100 Mn investment...

January 13, 2025 | News

Verismo Therapeutics Secures $4.05M Investment from IFLI to Advance SynKIR™-310 for Follicular Lymphoma

Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI). The partnership with...

January 08, 2025 | News

Stay Connected